Esperion Therapeutics (ESPR) stock forecast for 2024. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Esperion Therapeutics (ESPR) stock forecast for 2024

Updated: March 27, 2024 (11:15)

Sector: Healthcare

The share price of Esperion Therapeutics, Inc. (ESPR) now

What analysts predict: $7.41
52-week High/Low: $3.335 / $0.7

50/200 Day Moving Average: $2.376 / $1.674

This figure corresponds to the Average Price over the previous 50/200 days. For Esperion Therapeutics stocks, the 50-day moving average is the resistance level today.

For Esperion Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Esperion Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Esperion Therapeutics stock price in 2024. How much will one Esperion Therapeutics share be worth in 2024? Is it worth taking profit / loss on ESPR stock now or waiting? What are analysts' forecasts for Esperion Therapeutics stock?

We forecast Esperion Therapeutics stock performance using neural networks based on historical data on ESPR stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Esperion Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Esperion Therapeutics analysts is $7.41. Today 200 Day Moving Average is the support level (1.674 $). 50 Day Moving Average is the support level (2.376 $).




Historical and forecast chart of Esperion Therapeutics, Inc. stock

The chart below shows the historical price of Esperion Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ESPR stock price can be found in the table below.


Esperion Therapeutics is a publicly available US pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated LDL-C levels.

Esperion Therapeutics (ESPR) Forecast for 2024

Month Target Pes. Opt. Vol., %
Apr 3.05 2.36 3.32 28.90 %
May 3.63 2.88 4.43 34.95 %
Jun 3.93 3.01 4.39 31.42 %
Jul 4.29 3.34 4.74 29.59 %
Aug 4.73 4.45 5.48 18.90 %
Sep 4.56 3.66 5.12 28.58 %
Oct 4.52 4.05 5.58 27.47 %
Nov 4.95 4.55 5.43 16.15 %
Dec 5.62 4.88 6.31 22.71 %

Esperion Therapeutics information and performance

Esperion Therapeutics Address

3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US

Market Capitalization: 484 839 000 $

Market capitalization of the Esperion Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ESPR shares in the company outstanding by the market price of one share.

EBITDA: -155 399 008 $

EBITDA of Esperion Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -4.78

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.03

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.714
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 1.028

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 5.75

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.455

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 185053000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Esperion Therapeutics price target for 2024 by month


Target values for the price of one Esperion Therapeutics share for Apr 2024.

The weighted average target price per Esperion Therapeutics share in Apr 2024 is: 3.05.
In Apr, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.899% volatility is expected.
Pessimistic target level: 2.36
Optimistic target level: 3.32

Target values for the price of one Esperion Therapeutics share for May 2024.

The weighted average target price per Esperion Therapeutics share in May 2024 is: 3.63.
In May, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 34.947% volatility is expected.
Pessimistic target level: 2.88
Optimistic target level: 4.43

Target values for the price of one Esperion Therapeutics share for Jun 2024.

The weighted average target price per Esperion Therapeutics share in Jun 2024 is: 3.93.
In Jun, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 31.423% volatility is expected.
Pessimistic target level: 3.01
Optimistic target level: 4.39

Target values for the price of one Esperion Therapeutics share for Jul 2024.

The weighted average target price per Esperion Therapeutics share in Jul 2024 is: 4.29.
In Jul, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 29.593% volatility is expected.
Pessimistic target level: 3.34
Optimistic target level: 4.74

Target values for the price of one Esperion Therapeutics share for Aug 2024.

The weighted average target price per Esperion Therapeutics share in Aug 2024 is: 4.73.
In Aug, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.896% volatility is expected.
Pessimistic target level: 4.45
Optimistic target level: 5.48

Target values for the price of one Esperion Therapeutics share for Sep 2024.

The weighted average target price per Esperion Therapeutics share in Sep 2024 is: 4.56.
In Sep, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.584% volatility is expected.
Pessimistic target level: 3.66
Optimistic target level: 5.12

Target values for the price of one Esperion Therapeutics share for Oct 2024.

The weighted average target price per Esperion Therapeutics share in Oct 2024 is: 4.52.
In Oct, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 27.472% volatility is expected.
Pessimistic target level: 4.05
Optimistic target level: 5.58

Target values for the price of one Esperion Therapeutics share for Nov 2024.

The weighted average target price per Esperion Therapeutics share in Nov 2024 is: 4.95.
In Nov, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 16.150% volatility is expected.
Pessimistic target level: 4.55
Optimistic target level: 5.43

Target values for the price of one Esperion Therapeutics share for Dec 2024.

The weighted average target price per Esperion Therapeutics share in Dec 2024 is: 5.62.
In Dec, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.707% volatility is expected.
Pessimistic target level: 4.88
Optimistic target level: 6.31



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.